Therapeutic Asset Ratings

h002

her2bbζ/cd19t+ t cells

hlx301

imm60

Jab 21822

jk08

mdx2001

neo212

Neoantigen Specific Tcr-T Cell Drug Product

or502

PEXMETINIB

s241656

sbt6290

Spedox-6

S^3.15,S^3.22,S^3.29-[(1,3,5-triazinane-1,3,5-triyl)tris(3-oxopropane-3,1-diyl)]{N-[5-oxo-5-({L-valyl-N⁵-carbamoyl-L-ornithyl[(4-aminophenyl)methoxy]carbonyl-N-methyl-L-valyl-Lvalyl-(3R,4S,5S)-3-methoxy-5-methyl-4-(methylamino)heptanoyl-(2R,3R)-N-[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]-3-methoxy-2-methyl-3-[(2S)-pyrrolidin-2-yl]propanamide}-N2.1-yl)pentanoyl]-?-alanyldecakis(N-methylglycyl)-L-alanyl-N6-carbamimidoyl-L-lysyl-L-?-aspartyl-L-cysteinyl-(4R)-4-hydroxy-L-prolyl-L-leucyl-L-valyl-L-asparaginyl-L-prolyl-L-leucyl-L-cysteinyl-L-leucyl-L-histidyl-L-prolyl-D-?-aspartyl-L-tryptophyl-N6-carbamimidoyl-L-lysyl-Lcysteinamide}

tqb3728

Tub-040

Valemetostat

xnw5004

zg005

bay2862789

Cdx-585

Eli-002 7P

prt2527

ro7496353